The disease burden of gout in Asian countries and regions from 1990 to 2021, risk factors and forecast analysis: A systematic study of Asian disease burden in 2021.

The disease burden of gout in Asian countries and regions from 1990 to 2021, risk factors and forecast analysis: A systematic study of Asian disease burden in 2021.

Show other versions (1)

<h4>Objective</h4>Use the Global Burden of Disease (GBD) database to obtain gout's disease burden indicators, risk factors, 1990-2021 data in Asian countries/regions and 2050 forecast data for gout prevention and control basis.<h4>Methods</h4>Collect gout prevalence, inc...

Full description

Saved in:
Bibliographic Details
Main Authors: Fuyu Yang, Runze Chen, Jun Xiong, Wenzhen Wang, Peng Yu, Huilin Wang
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2025-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0328543
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:<h4>Objective</h4>Use the Global Burden of Disease (GBD) database to obtain gout's disease burden indicators, risk factors, 1990-2021 data in Asian countries/regions and 2050 forecast data for gout prevention and control basis.<h4>Methods</h4>Collect gout prevalence, incidence etc. from global burden of disease data in Asia, stratified by gender and age, analyze with statistical charts. Use Joinpoint regression model for trend analysis. Predict 2050 East Asia incidence rate with Bayesian Age-Period-Cohort (BAPC) model.<h4>Results</h4>1990 - 2021, Age-standardized Prevalence Rate (ASPR) and Age-standardized Incidence Rate (ASIR) rose globally, in Asia and SDI regions. East Asia's incidence rose fast. Men's ASPR is nearly three times that of women. 55-59 - year - olds have the highest incidence rate in 2021. High BMI patients are common, and low proportion of kidney dysfunction impairment. East Asia's ASIR will rise by 2050 but slower.<h4>Conclusion</h4>Gout's disease burden rose in Asia 1990-2021. Prevalence and incidence vary by country/region, especially in East Asia. Men's prevalence is higher. 55-59 - year - olds have the highest prevalence. In Asia's developed countries, prevalence and incidence are above the global average in 2021. High BMI and kidney dysfunction impairment are key risk factors. These findings necessitate preventive strategies, enhanced cooperation in prevention and control management, public awareness campaigns, and early treatment interventions.
ISSN:1932-6203

Similar Items